Company Filing History:
1 out of 3 
1 out of 2 
1 out of 1 Years Active: 2016-2017
Title: Marcin Nowotny: Innovator in Cancer Treatment
Introduction
Marcin Nowotny is a prominent inventor based in Warsaw, Poland. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, his work focuses on developing therapeutic agents that target specific cancer-related mechanisms.
Latest Patents
Marcin Nowotny's latest patents include a method for the selection of hDIS3 PIN domain inhibitors and their application in cancer treatment. This invention relates to a method for screening hDIS3 PIN domain inhibitors, which are crucial for treating cancers with mutations in the hDIS3 RNB domain, particularly multiple myeloma. Additionally, he has developed a composition that includes a new therapeutic agent, hDIS3 PIN domain inhibitor, and a method for inducing synthetic lethality in cancer cells.
Another notable patent involves a sequence-specific engineered ribonuclease H. This invention focuses on a ribonuclease that cleaves the RNA strand in DNA-RNA hybrids. The ribonuclease comprises a fusion protein that includes the catalytic domain of RNase HI and a zinc finger DNA-RNA hybrid binding domain. This innovation allows for the determination of the sequence preference of DNA-RNA hybrid binding proteins, enhancing the understanding of their interactions.
Career Highlights
Throughout his career, Marcin Nowotny has worked with esteemed organizations such as the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences and Oncoarendi Therapeutics Sp. z o.o. His work in these institutions has contributed to advancements in biochemistry and therapeutic development.
Collaborations
Marcin has collaborated with notable colleagues, including Andrzej Dziembowski and Rafal Tomecki. These partnerships have fostered a collaborative environment that promotes innovative research and development in the field of cancer treatment.
Conclusion
Marcin Nowotny's contributions to cancer research through his patented inventions highlight his role as a key innovator in the field. His work continues to pave the way for new therapeutic strategies that could significantly impact cancer treatment.